October 2, 2017
Toronto, October 2, 2017 – The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Doug Sommerville, Senior Vice President and General Manager of Teva Canada, as Chair of CGPA, and, Jean-Guy Goulet, Chief Operating Officer of Pharmascience as Vice Chair of CGPA.
September 22, 2017
North American Generic and Biosimilar Medicines Industries Release Priorities for Renegotiation of NAFTA
September 21, 2017
Toronto, September 21, 2017 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding today’s provisional application of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union, which includes extensive changes to Canada’s intellectual property regime for pharmaceuticals.